000 | 01992 a2200565 4500 | ||
---|---|---|---|
005 | 20250513194706.0 | ||
264 | 0 | _c19991116 | |
008 | 199911s 0 0 eng d | ||
022 | _a0041-1337 | ||
024 | 7 |
_a10.1097/00007890-199910270-00010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlexander, J W | |
245 | 0 | 0 |
_aEvaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. _h[electronic resource] |
260 |
_bTransplantation _cOct 1999 |
||
300 |
_a1117-24 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aBlood Preservation |
650 | 0 | 4 | _aBlood Transfusion |
650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xanalysis |
650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xanalysis |
650 | 0 | 4 | _aHistocompatibility Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 | _aLiving Donors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPostoperative Care |
650 | 0 | 4 | _aPreoperative Care |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aLight, J A | |
700 | 1 | _aDonaldson, L A | |
700 | 1 | _aDelmonico, F L | |
700 | 1 | _aDiethelm, A G | |
700 | 1 | _aWilkinson, A | |
700 | 1 | _aRosenthal, J T | |
700 | 1 | _aThistlethwaite, J R | |
700 | 1 | _aHunsicker, L G | |
700 | 1 | _aMatas, A J | |
700 | 1 | _aFirst, M R | |
700 | 1 | _aReinsmoen, N L | |
700 | 1 | _aRose, S M | |
773 | 0 |
_tTransplantation _gvol. 68 _gno. 8 _gp. 1117-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007890-199910270-00010 _zAvailable from publisher's website |
999 |
_c10508277 _d10508277 |